Act as a World-Class Professor of General Medicine, Clinical Pharmacology, Pathology, and Medical Education. Teach me myocardial infarction disease in a simple, exam-oriented, and clinically practical manner. For every disease, follow this format: 1. Definition - One-line exam definition - Simple explanation 2. Causes (Etiology) - Common causes - Important risk factors 3. Types / Classification - Brief explanation of each type 4. Pathophysiology - Step-by-step flowchart with arrows - Easy to understand 5. Clinical Features - Symptoms - Signs - Explain why important symptoms occur 6. Key Symptoms That Suggest the Diagnosis - Hallmark symptom - Classic clinical clues - Red flag findings 7. Laboratory Investigations Create a table: Investigation | Expected Finding | Clinical Significance Include: - CBC - Biochemistry - Disease-specific tests - Imaging findings if relevant 8. Differential Diagnosis Create a comparison table: Disease | Similar Features | Differentiating Features 9. Short Clinical Case Example format: "A 55-year-old male presents with chest pain radiating to the left arm, sweating, and breathlessness. ECG shows ST elevation in leads II, III, and aVF. Troponin-I is elevated." Diagnosis: Reasoning: Provide only 1–2 short high-yield cases. 10. Treatment A. Non-Pharmacological Treatment B. Pharmacological Treatment Create a table: Drug | Drug Group | Mechanism of Action | Indication | Dose | Major Adverse Effects For every disease mention: - Drug of Choice (DOC) - First-line drugs - Alternative drugs - Emergency drugs (if applicable) 11. Clinical Pearls - Important bedside clues - High-yield exam facts - Viva points 12. Common Diagnostic Mistakes - Frequently missed findings - Common confusion with other diseases - How to avoid errors 13. 5-Minute Revision Summary Definition → Causes → Pathophysiology → Symptoms → Investigations → Treatment → Complications Teaching Rules: - Use simple English. - Explain like teaching a final-year medical student. - Use tables and flowcharts. - Focus on practical diagnosis and treatment. - Focus on exam-oriented points. - Mention standard drug doses whenever possible. - Keep the explanation concise but complete.

Reading File
Finding Sources
Searching PubMed

"myocardial infarction" AND "management"

Reading File
Reading File
Reading File
Reading File
Reading File
Finding Sources
Reading File
Finding Sources
Finding Sources
Reading File
Reading File
Reading File
Reading File
Reading File
Reading File
I now have rich, comprehensive content from multiple authoritative textbooks. I have enough to construct the full teaching module. Let me now compile the definitive answer.

🫀 MYOCARDIAL INFARCTION (MI)

A Complete Exam-Oriented, Clinically Practical Teaching Module

Sources: Robbins & Kumar Pathologic Basis of Disease | Braunwald's Heart Disease | Guyton & Hall Medical Physiology | Ganong's Review of Medical Physiology | Washington Manual of Medical Therapeutics | Goldman-Cecil Medicine | 2025 ACC/AHA Guidelines

1. DEFINITION

One-line exam definition:
Myocardial Infarction is the irreversible death (necrosis) of cardiac muscle caused by prolonged ischemia, most commonly due to occlusion of a coronary artery by atherosclerotic plaque rupture with superimposed thrombosis.
Simple explanation: Think of the heart as a pump that needs a constant supply of blood. The coronary arteries are its fuel lines. When one of these fuel lines gets blocked (by a clot forming on a ruptured plaque), the heart muscle downstream is starved of oxygen. Within 20-40 minutes, those muscle cells begin to die permanently. That dying zone is the infarct.
Key phrase: "Time is Myocardium" - every minute of delay = more dead muscle.

2. CAUSES (ETIOLOGY)

Common Causes

CauseMechanismFrequency
Atherosclerotic plaque rupture + thrombosisExposes subendothelial collagen → platelet aggregation → thrombus~90%
Coronary vasospasm (Prinzmetal angina)Smooth muscle contraction, +/- cocaine or ephedrine~5%
Coronary embolismFrom mural thrombus (AF), endocarditis, prosthetic valve~2-3%
Small vessel diseaseVasculitis, amyloid, sickle cell diseaseRare
Demand ischemia (Type 2 MI)Severe anemia, tachyarrhythmia, shockOccasional

Important Risk Factors

Non-modifiable: Age (males >45y, females >55y), male sex, family history, genetics
Modifiable (Big 6):
  1. Smoking (most powerful risk factor in young patients)
  2. Hypertension
  3. Diabetes mellitus
  4. Dyslipidemia (high LDL, low HDL)
  5. Obesity
  6. Sedentary lifestyle
Important extra: Post-menopausal females lose estrogen protection → IHD becomes the leading cause of death in older women. Hormone replacement therapy does NOT protect and may be pro-thrombotic.

3. TYPES / CLASSIFICATION

A. By ECG Pattern (Most Important Clinically)

TypeECG FindingPathologyVessel
STEMI (ST-Elevation MI)ST elevation + Q wavesFull-thickness (transmural) necrosisComplete occlusion
NSTEMI (Non-ST Elevation MI)ST depression / T-wave inversion + positive troponinSubendocardial necrosisPartial/transient occlusion
Unstable Angina (UA)ST depression / T-wave inversion + negative troponinIschemia, no necrosisPartial occlusion
STEMI + NSTEMI + UA = collectively called Acute Coronary Syndrome (ACS)

B. By Depth of Necrosis

TypeDescription
TransmuralFull thickness of ventricular wall - causes STEMI; higher complication risk
SubendocardialInner 1/3 of wall - NSTEMI; subendocardium is most vulnerable (last to receive blood, compressed by systole)

C. By Universal Classification (for viva)

TypeCause
Type 1Spontaneous - plaque rupture/erosion
Type 2Demand ischemia (supply-demand mismatch)
Type 3Sudden cardiac death before biomarker results
Type 4a/bPCI-related / stent thrombosis
Type 5CABG-related

D. By Location

Artery OccludedInfarct LocationECG Leads Affected
LAD (40-50%)Anterior wall, anterior septum, apexV1-V4
RCA (30-40%)Inferior/posterior wall, posterior septumII, III, aVF
LCx (15-20%)Lateral wallI, aVL, V5-V6

4. PATHOPHYSIOLOGY

Step-by-Step Flowchart

Risk factors (HTN, DM, smoking, dyslipidemia)
        ↓
Endothelial injury → Atherosclerotic plaque formation in coronary artery
        ↓
Plaque rupture / erosion (triggered by shear stress, inflammation)
        ↓
Subendothelial collagen + plaque contents exposed to blood
        ↓
Platelet adhesion → Activation → Aggregation
(release Thromboxane A2, ADP, serotonin → vasoconstriction + more platelet aggregation)
        ↓
Coagulation cascade activated (Tissue Factor) → Fibrin clot forms
        ↓
Coronary artery OCCLUSION (thrombus complete within minutes)
        ↓
Blood flow ceases to downstream myocardium (area at risk)
        ↓
Aerobic metabolism STOPS within seconds
→ ATP production falls
→ Creatine phosphate depleted
→ Lactic acid accumulates
        ↓
Contractility LOST within <2 minutes (stunning begins)
        ↓
~20-40 minutes: IRREVERSIBLE CELL DEATH begins (necrosis)
(subendocardium first → wavefront progresses outward to epicardium)
        ↓
Sarcolemmal membrane disruption
→ Intracellular proteins leak into bloodstream
→ Troponin I, Troponin T, CK-MB detected in blood ← BASIS OF BLOOD TESTS
        ↓
6-12 hours: Necrosis becomes complete
        ↓
Inflammatory response: Neutrophils → Macrophages → Granulation tissue
        ↓
2-8 weeks: Fibrous SCAR formation (thin, non-contractile)
        ↓
Complications: Pump failure, arrhythmia, rupture, aneurysm

Key Biochemical Timeline (from Robbins):

EventTime
ATP depletion beginsSeconds
Loss of contractility<2 minutes
ATP at 50% of normal10 minutes
ATP at 10% of normal40 minutes
Irreversible cell injury20-40 minutes
Microvascular injury>1 hour
Complete necrosis6-12 hours

Why the Subendocardium Dies First:

The subendocardium is the "perfect victim" - it receives blood last from the epicardial vessels AND is compressed by high intramural pressures during systole, making it most sensitive to any drop in coronary flow.

5. CLINICAL FEATURES

Symptoms

SymptomDescriptionWhy It Occurs
Chest painCrushing, heavy, tight, "elephant on chest"Ischemic tissue releases adenosine, bradykinin, histamine → stimulate cardiac pain fibers (C-fibers)
RadiationLeft arm, jaw, neck, shoulder, epigastriumShared dermatomal pathway (T1-T4) - visceral referred pain
Duration>30 minutes, not relieved by nitratesUnlike stable angina which resolves <20 min
Diaphoresis (sweating)Cold, clammy sweatMassive sympathetic activation (catecholamine surge)
BreathlessnessDyspnoea, orthopnoeaLV failure → pulmonary congestion
Nausea / VomitingParticularly with inferior MIVagal activation (RCA supplies AV node + vagal input)
Dizziness / SyncopeLight-headednessReduced cardiac output
Sense of doomImpending death feelingSevere sympathetic activation

Signs

SignWhat It Means
Pallor, cold clammy skinVasoconstriction + reduced output
TachycardiaCompensatory sympathetic activation
BradycardiaInferior MI - vagal overstimulation
HypotensionCardiogenic shock, large infarct
S4 gallopReduced LV compliance (stiff ventricle)
S3 gallopLV failure (large infarct with poor function)
Elevated JVPRV infarction or LV failure
Pulmonary crackles (basal)Pulmonary oedema (LV failure)
New murmurPapillary muscle rupture (MR) or VSD rupture

Atypical Presentations (High-yield - don't miss!)

  • Elderly: Breathlessness alone, confusion, falls
  • Diabetics: "Silent MI" - no pain (autonomic neuropathy blunts pain sensation)
  • Women: Fatigue, jaw pain, epigastric discomfort - often misdiagnosed
  • Inferior MI: Epigastric pain + vomiting - often mistaken for peptic ulcer!

6. KEY SYMPTOMS THAT SUGGEST DIAGNOSIS

Hallmark Symptom

Crushing central chest pain lasting >30 minutes, radiating to the left arm/jaw, NOT relieved by nitrates, accompanied by diaphoresis

Classic Clinical Clues

ClueSignificance
Pain >30 min, not relieved by rest/nitratesDistinguishes MI from stable angina
Diaphoresis (cold sweat)Massive sympathetic activation
Radiation to jaw/left armClassic referred pain
Nausea + vomitingInferior MI (vagal)
New S4 at bedsideIschemia causing stiff ventricle
Epigastric pain in known diabeticSilent MI, always check ECG + troponin

Red Flag Findings (Require Immediate Action)

Red FlagIndicates
ST elevation on ECGSTEMI → emergency PCI within 90 min
New LBBBEquivalent to STEMI
Rising troponinActive myocardial necrosis
Cardiogenic shockMassive MI (>40% LV loss)
New murmurMechanical complication (papillary rupture, VSD)
Bradycardia + hypotensionRV infarction / complete heart block (inferior MI)

7. LABORATORY INVESTIGATIONS

InvestigationExpected FindingClinical Significance
Troponin I / T (hs-cTn)Elevated (rises 3-4h, peaks 12-24h, stays up 7-10 days)Gold standard biomarker of myocardial necrosis; rise + fall pattern distinguishes MI from other causes
CK-MBElevated (rises 3-6h, peaks 24h, normalises 48-72h)Useful for detecting reinfarction (short window); no longer recommended for initial NSTEMI diagnosis
LDH (LDH1 > LDH2)LDH1/LDH2 flipUsed historically; elevated for up to 14 days; useful when patient presents late
MyoglobinEarliest rise (1-2h); nonspecificFirst to rise but also elevated in skeletal muscle injury; not cardiac-specific
CBCLeukocytosis (neutrophilia)Inflammatory response to necrosis; peaks day 2-3; anemia worsens ischemia
Blood glucoseOften elevated (stress hyperglycaemia)Poorer prognosis if elevated; uncontrolled DM increases risk
Lipid profileTotal cholesterol, LDL, HDL, TGIdentify and treat dyslipidaemia; note: LDL falsely low acutely - check at admission or after 6 weeks
BMP / Renal functionMay show renal impairmentAffects drug dosing (heparin, contrast); elevated creatinine = worse prognosis
BNP / NT-proBNPElevatedMarker of myocardial stress; high BNP = large infarct, urgent angiography
Coagulation (PT/INR, aPTT)Baseline neededBefore anticoagulation/thrombolysis
ECGST elevation (STEMI), ST depression/T inversion (NSTEMI), Q waves (old MI)Location of infarct; identifies STEMI for emergency reperfusion
Echocardiography (2D Echo)Regional wall motion abnormality (RWMA), reduced EFConfirms ischemia; assesses LV function; detects complications (MR, VSD, pericardial effusion)
Chest X-rayPulmonary oedema, cardiomegalyDetects pulmonary congestion, excludes pneumothorax/aortic dissection
Coronary AngiographyCulprit vessel occlusionDefinitive diagnosis + allows PCI (therapeutic)
Cardiac MRIInfarct size, viability, microvascular obstructionNot used acutely; useful for viability and prognosis assessment

Biomarker Timeline (High-Yield Chart)

Hours:       0    2    4    6    12   24   48   72   96   7d   10d  14d
Myoglobin:   ——RISE——PEAK——FALL—————————
CK-MB:            ———RISE——————PEAK———FALL——————————
Troponin I:             ——RISE————————PEAK(24h)————————————————FALL(7-10d)
LDH:                              ——RISE——————PEAK(3-4d)—————————————FALL(14d)

8. DIFFERENTIAL DIAGNOSIS

DiseaseSimilar FeaturesDifferentiating Features
Unstable AnginaChest pain, ECG changes, risk factorsTroponin NEGATIVE; pain relieved by nitrates; no permanent necrosis
Aortic DissectionSevere chest pain, diaphoresis, may cause MIPain is tearing, ripping, radiates to back, unequal BP in arms, wide mediastinum on CXR, no troponin rise early
Pulmonary EmbolismChest pain, dyspnoea, tachycardiaPleuritic pain (worse on breathing), hypoxia, S1Q3T3 on ECG, D-dimer elevated, CT-PA confirms
PericarditisChest pain, ECG changes (ST elevation)Pain positional (better sitting forward, worse lying), saddle-shaped ST elevation in ALL leads, no Q waves, friction rub, troponin mildly elevated
Peptic Ulcer / GORDEpigastric pain, nausea, vomitingNo ECG changes, no troponin rise, pain related to food, relieved by antacids
Oesophageal SpasmChest pain, may radiate to armNo ECG changes, no troponin rise, relieved by nitrates (mimics angina), barium swallow confirms
MyocarditisChest pain, troponin elevation, ECG changesUsually young patients, viral prodrome, diffuse ST changes, echo shows global (not regional) dysfunction
PneumothoraxSudden chest pain, dyspnoeaAbsent breath sounds, tracheal deviation, hyperresonance, CXR shows collapsed lung

9. SHORT CLINICAL CASES

Case 1 - Classic STEMI

"A 58-year-old male smoker with known hypertension presents to the ER with crushing central chest pain of 2 hours duration radiating to the left jaw and arm, associated with profuse sweating and nausea. BP 95/60, HR 108, RR 22. ECG shows 3mm ST elevation in leads II, III, and aVF. Troponin-I is markedly elevated. Pulses are equal bilaterally."
Diagnosis: Inferior STEMI (Right Coronary Artery territory)
Reasoning:
  • ST elevation in II, III, aVF = inferior wall = RCA territory
  • Classic crushing chest pain >30 min + diaphoresis
  • Nausea and bradycardia tendency = vagal activation (inferior MI hallmark)
  • Hypotension = may indicate RV involvement or early cardiogenic shock
  • Positive troponin = myocardial necrosis confirmed
  • Equal BP in both arms = rules out aortic dissection
Action: Activate cath lab - target door-to-balloon time <90 min

Case 2 - NSTEMI / Diabetic Silent Presentation

"A 67-year-old diabetic female presents with a 12-hour history of severe fatigue, mild jaw discomfort, and breathlessness. No obvious chest pain. ECG shows 2mm ST depression in V4-V6. High-sensitivity troponin-T is 0.08 ng/mL (elevated) with a 3-hour repeat of 0.14 ng/mL (significant rise)."
Diagnosis: NSTEMI
Reasoning:
  • Atypical presentation (fatigue, jaw pain) - classic in women and diabetics
  • No ST elevation → not STEMI; troponin positive → not unstable angina → NSTEMI
  • Rising troponin (delta troponin >20% rise) confirms active necrosis
  • ST depression in V4-V6 = lateral ischemia
  • Diabetic autonomic neuropathy blunts classic chest pain
Action: Antiplatelet therapy + anticoagulation + early invasive strategy within 24h

10. TREATMENT

A. Non-Pharmacological Treatment

  1. Immediate rest - reduce myocardial oxygen demand
  2. Oxygen - only if SpO2 <90% (routine oxygen is NOT recommended if SpO2 normal - it causes vasoconstriction)
  3. IV access - two large-bore cannulas
  4. Cardiac monitoring - continuous ECG, pulse oximetry
  5. Reperfusion (the most important treatment):
    • Primary PCI (percutaneous coronary intervention) = Drug of Choice for STEMI if available within 120 min (target: door-to-balloon <90 min)
    • Thrombolysis (fibrinolytic therapy) = if PCI not available within 120 min (give within 30 min of arrival - "door-to-needle time")
    • CABG (coronary artery bypass graft) = for multi-vessel disease, failed PCI, left main disease
  6. Cardiac rehabilitation after discharge
  7. Lifestyle modification: Smoking cessation, diet, exercise, weight loss

B. Pharmacological Treatment

DrugDrug GroupMechanism of ActionIndicationStandard DoseMajor Adverse Effects
Aspirin (DOC/First-line)Antiplatelet (COX-1 inhibitor)Irreversibly inhibits COX-1 → blocks TXA2 → reduces platelet aggregationAll ACS immediately; continues lifelongLoading: 300mg PO stat, then 75-100mg ODGI bleeding, peptic ulcer
ClopidogrelAntiplatelet (P2Y12 blocker)Irreversibly blocks ADP receptor (P2Y12) on plateletsNSTEMI (if no PCI); with aspirin = DAPTLoading: 300mg, then 75mg ODBleeding; resistance in ~30% (CYP2C19 polymorphism)
Ticagrelor (Preferred P2Y12)Antiplatelet (P2Y12 blocker)Reversibly blocks P2Y12 receptorSTEMI + NSTEMI with PCI; preferred over clopidogrelLoading: 180mg, then 90mg BDDyspnoea (via adenosine), bleeding; avoid with strong CYP3A4 inhibitors
PrasugrelAntiplatelet (P2Y12 blocker)Irreversible P2Y12 block (faster onset than clopidogrel)STEMI with PCILoading: 60mg, then 10mg ODHigher bleeding risk; contraindicated in prior stroke/TIA, age >75y
Unfractionated Heparin (UFH)AnticoagulantActivates antithrombin III → inhibits thrombin (IIa) and Factor XaAcute ACS, during PCI60 units/kg IV bolus (max 4000 units) + infusionBleeding, HIT (heparin-induced thrombocytopenia)
Enoxaparin (LMWH)AnticoagulantPrimarily inhibits Factor Xa via antithrombin IIINSTEMI/UA; alternative to UFH1mg/kg SC BD (reduce to OD if CrCl <30)Bleeding; less HIT than UFH; not reversible with protamine
MorphineOpioid analgesicActivates mu-opioid receptors → analgesia + venodilation (reduces preload)Severe chest pain unresponsive to nitrates2-4mg IV, repeat every 5-15 minNausea, respiratory depression, hypotension; caution: may delay P2Y12 drug absorption
Nitrates (GTN)VasodilatorReleases NO → cGMP → smooth muscle relaxation → venodilation (↓ preload) and coronary vasodilationChest pain, hypertension; NOT if RV infarction0.4mg sublingual, repeat x3; or IV infusionHeadache, hypotension; contraindicated in RV infarction, hypotension, with PDE5 inhibitors
Metoprolol / BisoprololBeta-1 blockerBlocks beta-1 receptors → ↓HR, ↓contractility → ↓oxygen demand; anti-arrhythmicAll MI (start within 24h if stable); continue lifelongMetoprolol 25-50mg BD PO (IV if hypertensive)Bradycardia, AV block, bronchospasm; contraindicated in acute HF, bradycardia, severe LV dysfunction
ACE Inhibitor (Ramipril/Lisinopril)ACE InhibitorBlocks RAAS → reduces afterload → prevents LV remodellingAll MI, especially with reduced EF or DM; start within 24hRamipril 2.5-5mg BD; titrateDry cough, hyperkalaemia, renal impairment; contraindicated in bilateral RAS, pregnancy
AtorvastatinHMG-CoA reductase inhibitor (Statin)Reduces LDL synthesis; stabilises plaques; anti-inflammatoryAll ACS - high-intensity statin immediately40-80mg OD (high intensity)Myopathy, hepatotoxicity (rare), elevated LFTs
Streptokinase / Alteplase (tPA)Thrombolytic (Fibrinolytic)Activates plasminogen → plasmin → dissolves thrombusSTEMI when PCI unavailable within 120 min; give within 12h of symptom onsetStreptokinase 1.5 million units IV over 60 min / Alteplase weight-basedMajor bleeding, intracranial haemorrhage (0.5-1%), allergic reaction (streptokinase)
Spironolactone / EplerenoneAldosterone antagonistBlocks aldosterone receptor → prevents cardiac fibrosis and remodellingPost-MI with EF <40% + HF or DMEplerenone 25-50mg ODHyperkalaemia, gynecomastia (spironolactone)

Summary - Drug Priority

PriorityDrug
DOC for reperfusion (STEMI)Primary PCI (not a drug, but the treatment)
DOC for antiplateletsAspirin (lifelong) + Ticagrelor (preferred P2Y12 for PCI)
DOC for thrombolysisAlteplase (tPA) if PCI unavailable
Emergency analgesicIV Morphine
Emergency vasodilatorSublingual GTN
Long-term preventionAspirin + Statin + ACEi + Beta-blocker ("ASAB" mnemonic)

MONA mnemonic (Emergency Initial Therapy)

M - Morphine (pain relief) O - Oxygen (if SpO2 <90%) N - Nitrates (sublingual GTN) A - Aspirin (300mg chewed)
(+ Add Anticoagulation + P2Y12 inhibitor)

11. CLINICAL PEARLS

Bedside Clues

  • A patient with crushing chest pain + diaphoresis + new S4 = MI until proven otherwise
  • Inferior MI loves to cause bradycardia and vomiting (vagal effect - RCA supplies SA node + vagal fibers)
  • A new pansystolic murmur 2-5 days post-MI = papillary muscle rupture (MR) or VSD - surgical emergency
  • RV infarction triad: hypotension + elevated JVP + clear lungs (no pulmonary oedema) - occurs with inferior STEMI; give IV fluids, avoid nitrates!
  • Dressler syndrome = pericarditis 2-6 weeks post-MI (immune-mediated) - treat with NSAIDs/aspirin

High-Yield Exam Facts

  • Angiography within 4 hours of MI shows thrombosis in 90% of cases
  • By 12-24h, thrombosis seen in only 60% (spontaneous lysis occurs)
  • 20-40 minutes = window for irreversible damage; beyond 6-12 hours = complete necrosis
  • Subendocardium dies FIRST (most vulnerable zone)
  • Reperfusion injury causes contraction band necrosis - characteristic microscopically
  • Troponin is the GOLD STANDARD biomarker (CK-MB no longer recommended for initial NSTEMI diagnosis)
  • LAD occlusion = most common (40-50%), called the "widow maker"
  • Q waves on ECG = old/completed infarct (dead electrically silent tissue)
  • Wellens syndrome = critical LAD stenosis; biphasic T-waves in V2-V3 even when pain-free - do NOT stress test!
  • The 2025 ACC/AHA Guidelines (PMID: 40013746) update STEMI/NSTEMI management with ticagrelor preferred over clopidogrel

Viva Points

  • "Why does the subendocardium infarct first?" → Last to receive blood + highest oxygen demand + compressed by systolic pressure
  • "What is stunned myocardium?" → Reversible contractile dysfunction after brief ischemia; recovers in days-weeks
  • "What is hibernating myocardium?" → Chronically ischemic but viable muscle with reduced function; revascularization restores function
  • "Why does LDL appear falsely low in acute MI?" → Acute phase response lowers cholesterol; check lipids at admission or >6 weeks later
  • "What is reperfusion injury?" → Paradoxical increase in damage when blood flow is restored; mediated by free radicals, calcium overload, mitochondrial dysfunction

12. COMMON DIAGNOSTIC MISTAKES

MistakeWhy It HappensHow to Avoid
Missing inferior MI in a "GI" patientInferior MI = epigastric pain + vomiting mimics PUDAlways do ECG + troponin in any patient >40y with epigastric pain/vomiting
Missing silent MI in diabeticsAutonomic neuropathy - no pain sensationLow threshold for ECG + troponin in diabetics with fatigue/breathlessness
Mistaking pericarditis for STEMIBoth have ST elevationPericarditis: saddle-shaped, all leads, no Q waves, positional pain, friction rub, responds to NSAIDs
Missing aortic dissectionBoth cause severe chest painLook for unequal BP in arms, tearing/ripping quality, wide mediastinum; doing thrombolysis in dissection = fatal
Giving nitrates in RV infarctionRV depends on preload; nitrates drop preload → severe hypotensionIn inferior MI with hypotension + raised JVP + clear lungs → suspect RV MI → give IV fluids, avoid nitrates
Ignoring Wellens syndromeECG done when pain-free looks "normal" but has biphasic T-waves V2-V3Never stress test a Wellens patient - they have critical LAD stenosis; go straight to angiography
Falsely reassuring LDL value in acute MILDL drops during acute phase responseAlways note timing; recheck after 6 weeks or trust admission value
Delaying treatment waiting for troponinTroponin takes 3-4 hours to riseTreat STEMI on ECG + clinical grounds; don't wait for troponin result to activate cath lab

13. 5-MINUTE REVISION SUMMARY

DEFINITION
→ Irreversible death of cardiac muscle due to prolonged coronary ischemia
→ ~800,000 cases/year in USA; 1 MI every 40 seconds

CAUSES
→ 90%: Atherosclerotic plaque rupture + coronary thrombosis
→ Risk: Smoking, HTN, DM, Dyslipidaemia, Age, Male sex
→ Rare: Vasospasm, embolism, vasculitis

PATHOPHYSIOLOGY
→ Plaque rupture → Platelet aggregation → Thrombus → Coronary occlusion
→ Ischemia → ATP depleted → Contractility lost (<2 min)
→ Irreversible necrosis at 20-40 min → Complete by 6-12h
→ Subendocardium first; transmural = STEMI; subendocardial = NSTEMI
→ Proteins leak → Troponin detectable in blood (3-4 hours)

SYMPTOMS
→ Crushing central chest pain >30 min, radiates to left arm/jaw
→ Diaphoresis, nausea, breathlessness
→ Silent in diabetics and elderly!

INVESTIGATIONS
→ ECG: ST elevation (STEMI) / ST depression (NSTEMI) / Q waves (old MI)
→ Troponin: Gold standard - rises 3-4h, peaks 24h, stays 7-10 days
→ CK-MB: Useful for reinfarction
→ Echo: Wall motion abnormality (RWMA), assess LV function
→ Coronary angiography: Definitive + therapeutic (PCI)

TREATMENT
Emergency: MONA (Morphine, O2, Nitrates, Aspirin 300mg) + Anticoagulation + P2Y12
Reperfusion: Primary PCI <90 min (door-to-balloon) is DOC
              Thrombolysis if PCI unavailable within 120 min
Long-term: Aspirin + Statin (atorvastatin 80mg) + ACEi + Beta-blocker

COMPLICATIONS
Early (hours-days):
→ Arrhythmias - most common cause of EARLY death (VF = #1 killer in first hour)
→ Cardiogenic shock (>40% LV loss)
→ Acute LV failure / pulmonary oedema
→ RV infarction (with inferior MI)
→ Papillary muscle rupture → acute MR (day 2-7)
→ VSD rupture (day 3-5)
→ Free wall rupture (day 5-10) → cardiac tamponade → death

Late (weeks-months):
→ LV aneurysm (persistent ST elevation, risk of mural thrombus/VT)
→ Dressler syndrome (autoimmune pericarditis, 2-6 weeks)
→ Heart failure (chronic)
→ Reinfarction

Recent Evidence Update (2025): The 2025 ACC/AHA Guideline for Acute Coronary Syndromes reinforces primary PCI as the gold standard, updates antiplatelet strategies (ticagrelor preferred over clopidogrel for most PCI patients), and refines risk stratification for NSTEMI management. A 2025 Lancet meta-analysis (PMID: 40902613) also revisited clopidogrel vs aspirin for long-term secondary prevention.

Sources consulted: Robbins & Kumar Pathologic Basis of Disease (9780443264528) | Guyton & Hall Medical Physiology (9780443111013) | Ganong's Review of Medical Physiology (9781260122404) | Washington Manual of Medical Therapeutics (9781975190620) | Braunwald's Heart Disease (9780323722193) | 2025 ACC/AHA ACS Guidelines (PMID: 40013746)
This is a shared conversation. Sign in to Orris to start your own chat.